In addition, we found that PSMA PET/CT also has a higher lesion DR in patients with low PSA level, indicating that this technique as a molecule-targeted diagnostic strategy is applicable to a wide population of PCa patients. Here, KLK3 is linked to posterior cortical atrophy.